期刊
MEDICAL CLINICS OF NORTH AMERICA
卷 103, 期 1, 页码 15-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.mcna.2018.08.002
关键词
PPI-refractory; Antireflux surgery; Fundoplication; Magnetic sphincter augmentation; Gastroesophageal reflux disease (GERD)
资金
- NIH [R01 DK092217]
- American College of Gastroenterology 2018 Junior Faculty Development Award
Proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD) is defined by the presence of troublesome GERD symptoms despite PPI optimization for at least 8 weeks in the setting of ongoing documented pathologic gastroesophageal reflux. It arises from a dysfunction in protective systems to prevent reflux and as propagation of physiologic reflux events. Treatment possibilities include pharmacologic options, invasive management strategies, and endoluminal therapies. Management strategy should be personalized to the patient's needs and mechanistic dysfunction. This article reviews the definition, mechanisms, and management options for PPI-refractory GERD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据